<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/"><channel><title>PeptideScanner evidence for Gallium Ga 68 dotatate</title><link>https://peptidescanner.com/peptides/gallium-ga-68-dotatate/</link><description>Versioned, source-linked PeptideScanner evidence objects for Gallium Ga 68 dotatate. Selected coverage; not medical advice.</description><language>en-us</language><atom:link href="https://peptidescanner.com/feeds/peptides/gallium-ga-68-dotatate.xml" rel="self" type="application/rss+xml"/><item><title>Drugs@FDA application NDA208547</title><link>https://peptidescanner.com/stories/fda-drugs-nda208547/</link><guid isPermaLink="false">urn:peptidescanner:story:fda-drugs-nda208547:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/gallium-ga-68-dotatate.json#fda-drugs-nda208547-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Regulatory; date in source 2016-06-01. PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.</description><dc:date>2026-11-17</dc:date><category>Regulatory</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT03206060</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct03206060-gallium-ga-68-dotatate/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct03206060-gallium-ga-68-dotatate:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/gallium-ga-68-dotatate.json#clinicaltrials-gov-nct03206060-gallium-ga-68-dotatate-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-10-26. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT03448458</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct03448458-gallium-ga-68-dotatate/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct03448458-gallium-ga-68-dotatate:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/gallium-ga-68-dotatate.json#clinicaltrials-gov-nct03448458-gallium-ga-68-dotatate-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2025-07-17. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT03953131</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct03953131-gallium-ga-68-dotatate/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct03953131-gallium-ga-68-dotatate:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/gallium-ga-68-dotatate.json#clinicaltrials-gov-nct03953131-gallium-ga-68-dotatate-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2023-09-01. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT04040088</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct04040088-gallium-ga-68-dotatate/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct04040088-gallium-ga-68-dotatate:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/gallium-ga-68-dotatate.json#clinicaltrials-gov-nct04040088-gallium-ga-68-dotatate-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-03-31. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT04069299</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct04069299-gallium-ga-68-dotatate/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct04069299-gallium-ga-68-dotatate:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/gallium-ga-68-dotatate.json#clinicaltrials-gov-nct04069299-gallium-ga-68-dotatate-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-03-31. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT07150806</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct07150806-gallium-ga-68-dotatate/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct07150806-gallium-ga-68-dotatate:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/gallium-ga-68-dotatate.json#clinicaltrials-gov-nct07150806-gallium-ga-68-dotatate-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-08-13. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>Doing Great With DOTATATE: Update on GA-68 DOTATATE Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging for Evaluation of Sinonasal Tumors.</title><link>https://peptidescanner.com/stories/pubmed-pmid-34096898-gallium-ga-68-dotatate/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-34096898-gallium-ga-68-dotatate:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/gallium-ga-68-dotatate.json#pubmed-pmid-34096898-gallium-ga-68-dotatate-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2021-06-16. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Incidental Papillary Thyroid Carcinoma Detected by Ga-68 DOTATATE PET/CT: A Rare Case Study and Clinical Considerations.</title><link>https://peptidescanner.com/stories/pubmed-pmid-38262470-gallium-ga-68-dotatate/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-38262470-gallium-ga-68-dotatate:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/gallium-ga-68-dotatate.json#pubmed-pmid-38262470-gallium-ga-68-dotatate-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2025-02-04. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>The lesion detection rate of Ga-68 DOTATATE PET/MR in multiple endocrine neoplasia type 1.</title><link>https://peptidescanner.com/stories/pubmed-pmid-38563291-gallium-ga-68-dotatate/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-38563291-gallium-ga-68-dotatate:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/gallium-ga-68-dotatate.json#pubmed-pmid-38563291-gallium-ga-68-dotatate-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2024-04-25. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Time-of-Flight PET/CT Imaging of Ga-68-Dotatate: Normal Pattern, SUV Quantification, and Differences from Non-Time-of-Flight Imaging.</title><link>https://peptidescanner.com/stories/pubmed-pmid-38933071-gallium-ga-68-dotatate/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-38933071-gallium-ga-68-dotatate:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/gallium-ga-68-dotatate.json#pubmed-pmid-38933071-gallium-ga-68-dotatate-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2024-06-28. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Training and assessing convolutional neural network performance in automatic vascular segmentation using Ga-68 DOTATATE PET/CT.</title><link>https://peptidescanner.com/stories/pubmed-pmid-38967895-gallium-ga-68-dotatate/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-38967895-gallium-ga-68-dotatate:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/gallium-ga-68-dotatate.json#pubmed-pmid-38967895-gallium-ga-68-dotatate-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2024-11-25. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Pulmonary Metastasis of Grade 1 Meningioma Mimicking a Carcinoid Tumor: A Case Report with FDG PET/CT, Ga-68 DOTATATE PET/CT, and Pathological Confirmation.</title><link>https://peptidescanner.com/stories/pubmed-pmid-42787917-gallium-ga-68-dotatate/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-42787917-gallium-ga-68-dotatate:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/gallium-ga-68-dotatate.json#pubmed-pmid-42787917-gallium-ga-68-dotatate-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-09-26. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item></channel></rss>
